{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:46Z","timestamp":1747207306094,"version":"3.40.5"},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"17","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>SARS-CoV-2 is a novel coronavirus that expanded worldwide, generating a pandemic of acute respiratory syndrome called \u201ccoronavirus disease 2019\u201d (COVID-19), which resulted in a global health crisis. The spectrum of COVID-19 manifestations ranges from none or mild symp-toms to severe respiratory failure associated with systemic manifestations, mostly gastrointestinal symptoms. Hypercoagulability is an important feature of COVID-19 disease, which can potentially influence patients\u2019 prognosis. Therefore, gastroenterologists should focus on subjects with concomi-tant hypercoagulable gastrointestinal disorders as they may display a higher risk of thrombotic complications during SARS-CoV-2 infection. The aim of this review is to summarize the available evidence regarding the interplay of the prothrombotic pathogenetic mechanisms of both COVID-19 and hypercoagulable digestive diseases and the possible clinical implications. We summarized the potential interplay of prothrombotic mechanisms of both COVID-19 and hypercoagulable digestive diseases in the graphical abstract.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450123666220922095913","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T04:29:43Z","timestamp":1663907383000},"page":"1611-1619","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gastrointestinal System: COVID-19 and Potential Mechanisms Associated\nwith Coagulopathy"],"prefix":"10.2174","volume":"23","author":[{"given":"Silvio","family":"Danese","sequence":"first","affiliation":[{"name":"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy"},{"name":"University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4308-7295","authenticated-orcid":true,"given":"Federica","family":"Furfaro","sequence":"additional","affiliation":[{"name":"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gabbiadini","sequence":"additional","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy"},{"name":"University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Zilli","sequence":"additional","affiliation":[{"name":"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Dal Buono","sequence":"additional","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Allocca","sequence":"additional","affiliation":[{"name":"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy"},{"name":"University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gionata","family":"Fiorino","sequence":"additional","affiliation":[{"name":"Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy"},{"name":"University Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"Zhu N.","year":"2020","unstructured":"Zhu N.; Zhang D.; Wang W.; A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020,382(8),727-733","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"Hu B.","year":"2021","unstructured":"Hu B.; Guo H.; Zhou P.; Shi Z.L.; Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021,19(3),141-154","journal-title":"Nat Rev Microbiol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(20)30129-8","volume":"20","author":"Wilder-Smith A.","year":"2020","unstructured":"Wilder-Smith A.; Chiew C.J.; Lee V.J.; Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis 2020,20(5),e102-e107","journal-title":"Lancet Infect Dis"},{"unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19 - 11 May 2020. Available from:  director-general\/speeches\/detail\/who-director-general-s-openingremarks-at-the-media-briefing-on-covid-19---11-may-2020","key":"ref=4"},{"unstructured":"World Health Organization. WHO Coronavirus (COVID-19)\nDashboard. Available from:","key":"ref=5"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Varga Z.","year":"2020","unstructured":"Varga Z.; Flammer A.J.; Steiger P.; Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020,395(10234),1417-1418","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10238-020-00648-x","volume":"20","author":"Gavriatopoulou M.","year":"2020","unstructured":"Gavriatopoulou M.; Korompoki E.; Fotiou D.; Organ-specific manifestations of COVID-19 infection. Clin Exp Med 2020,20(4),493-506","journal-title":"Clin Exp Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","volume":"80","author":"Fu L.","year":"2020","unstructured":"Fu L.; Wang B.; Yuan T.; Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect 2020,80(6),656-665","journal-title":"J Infect"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","volume":"383","author":"Berlin D.A.","year":"2020","unstructured":"Berlin D.A.; Gulick R.M.; Martinez F.J.; Severe COVID-19. N Engl J Med 2020,383(25),2451-2460","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s11739-020-02432-x","volume":"15","author":"Marietta M.","year":"2020","unstructured":"Marietta M.; Coluccio V.; Luppi M.; COVID-19, coagulopathy and venous thromboembolism: More questions than answers. Intern Emerg Med 2020,15(8),1375-1387","journal-title":"Intern Emerg Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.thromres.2020.08.022","volume":"196","author":"Kunutsor S.K.","year":"2020","unstructured":"Kunutsor S.K.; Laukkanen J.A.; Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis. Thromb Res 2020,196,27-30","journal-title":"Thromb Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"Tang N.","year":"2020","unstructured":"Tang N.; Li D.; Wang X.; Sun Z.; Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020,18(4),844-847","journal-title":"J Thromb Haemost"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"Wu C.","year":"2020","unstructured":"Wu C.; Chen X.; Cai Y.; Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus dis-ease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020,180(7),934-943","journal-title":"JAMA Intern Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","volume":"379","author":"Z&#xF6;ller B.","year":"2012","unstructured":"Z&#xF6;ller B.; Li X.; Sundquist J.; Sundquist K.; Risk of pulmonary embolism in patients with autoimmune disorders: A nationwide follow-up study from Sweden. Lancet 2012,379(9812),244-249","journal-title":"Lancet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.crohns.2013.09.021","volume":"8","author":"Fumery M.","year":"2014","unstructured":"Fumery M.; Xiaocang C.; Dauchet L.; Gower-Rousseau C.; Peyrin-Biroulet L.; Colombel J.F.; Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: A meta-analysis of observational studies. J Crohn\u2019s Colitis 2014,8(6),469-479","journal-title":"J Crohn\u2019s Colitis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.autrev.2014.07.004","volume":"13","author":"Lerner A.","year":"2014","unstructured":"Lerner A.; Blank M.; Hypercoagulability in celiac disease - An update. Autoimmun Rev 2014,13(11),1138-1141","journal-title":"Autoimmun Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1160\/TH16-06-0450","volume":"117","author":"Ambrosino P.","year":"2017","unstructured":"Ambrosino P.; Tarantino L.; Di Minno G.; The risk of venous thromboembolism in patients with cirrhosis. Thromb Haemost 2017,117(1),139-148","journal-title":"Thromb Haemost"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"Levi M.","year":"2020","unstructured":"Levi M.; Thachil J.; Iba T.; Levy J.H.; Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 2020,7(6),e438-e440","journal-title":"Lancet Haematol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M20-2003","volume":"173","author":"Wichmann D.","year":"2020","unstructured":"Wichmann D.; Sperhake J.P.; L&#xFC;tgehetmann M.; Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med 2020,173(4),268-277","journal-title":"Ann Intern Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/ageing\/afaa259","volume":"50","author":"Wu T.","year":"2021","unstructured":"Wu T.; Zuo Z.; Yang D.; Venous thromboembolic events in patients with COVID-19: A systematic review and meta-analysis. Age Ageing 2021,50(2),284-293","journal-title":"Age Ageing"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"100761","DOI":"10.1016\/j.blre.2020.100761","volume":"47","author":"Hadid T.","year":"2021","unstructured":"Hadid T.; Kafri Z.; Al-Katib A.; Coagulation and anticoagulation in COVID-19. Blood Rev 2021,47,100761","journal-title":"Blood Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","volume":"231","author":"Wright F.L.","year":"2020","unstructured":"Wright F.L.; Vogler T.O.; Moore E.E.; Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection. J Am Coll Surg 2020,231(2),193-203e1","journal-title":"J Am Coll Surg"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11739-020-02394-0","volume":"15","author":"Bazzan M.","year":"2020","unstructured":"Bazzan M.; Montaruli B.; Sciascia S.; Cosseddu D.; Norbiato C.; Roccatello D.; Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients. Intern Emerg Med 2020,15(5),861-863","journal-title":"Intern Emerg Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.30699\/ijp.2021.525280.2600","volume":"17","author":"Sarkardeh M.","year":"2022","unstructured":"Sarkardeh M.; Dalili A.; Tayyebi M.N.; Intestinal Infarction in COVID-19 Pandemic: A case series. Iran J Pathol 2022,17(1),85-90","journal-title":"Iran J Pathol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.surg.2020.04.035","volume":"168","author":"Ignat M.","year":"2020","unstructured":"Ignat M.; Philouze G.; Aussenac-Belle L.; Small bowel ischemia and SARS-CoV-2 infection: An underdiagnosed distinct clinical entity. Surgery 2020,168(1),14-16","journal-title":"Surgery"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"Ungaro R.","year":"2017","unstructured":"Ungaro R.; Mehandru S.; Allen P.B.; Peyrin-Biroulet L.; Colombel J.F.; Ulcerative colitis. Lancet 2017,389(10080),1756-1770","journal-title":"Lancet"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"Torres J.","year":"2017","unstructured":"Torres J.; Mehandru S.; Colombel J.F.; Peyrin-Biroulet L.; Crohn\u2019s disease. Lancet 2017,389(10080),1741-1755","journal-title":"Lancet"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2468-1253(19)30173-6","volume":"4","author":"Argollo M.","year":"2019","unstructured":"Argollo M.; Gilardi D.; Peyrin-Biroulet C.; Chabot J.F.; Peyrin-Biroulet L.; Danese S.; Comorbidities in inflammatory bowel disease: A call for action. Lancet Gastroenterol Hepatol 2019,4(8),643-654","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.20524\/aog.2021.0631","volume":"34","author":"Arvanitakis K.","year":"2021","unstructured":"Arvanitakis K.; Arvanitaki A.D.; Karkos C.D.; Zintzaras E.A.; Germanidis G.S.; The risk of venous thromboembolic events in patients with inflammatory bowel disease: A systematic review and meta-analysis. Ann Gastroenterol 2021,34(5),680-690","journal-title":"Ann Gastroenterol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/apt.12294","volume":"37","author":"Yuhara H.","year":"2013","unstructured":"Yuhara H.; Steinmaus C.; Corley D.; Meta-analysis: The risk of venous thromboembolism in patients with inflammatory bowel dis-ease. Aliment Pharmacol Ther 2013,37(10),953-962","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2174\/1389450121666200902164240","volume":"22","author":"Solitano V.","year":"2020","unstructured":"Solitano V.; Fiorino G.; D\u2019Amico F.; Peyrin-Biroulet L.; Danese S.; Thrombosis in IBD in the Era of JAK Inhibition. Curr Drug Targets 2020,22(1),126-136","journal-title":"Curr Drug Targets"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","volume":"102","author":"Danese S.","year":"2007","unstructured":"Danese S.; Papa A.; Saibeni S.; Repici A.; Malesci A.; Vecchi M.; Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am J Gastroenterol 2007,102(1),174-186","journal-title":"Am J Gastroenterol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1572-0241.2003.07491.x","volume":"98","author":"Papa A.","year":"2003","unstructured":"Papa A.; Danese S.; Grillo A.; Gasbarrini G.; Gasbarrini A.; Review article: Inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003,98(6),1247-1251","journal-title":"Am J Gastroenterol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.3748\/wjg.v20.i17.4857","volume":"20","author":"Magro F.","year":"2014","unstructured":"Magro F.; Soares J.B.; Fernandes D.; Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J Gastroenterol 2014,20(17),4857-4872","journal-title":"World J Gastroenterol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12959-015-0044-2","volume":"13","author":"Giannotta M.","year":"2015","unstructured":"Giannotta M.; Tapete G.; Emmi G.; Silvestri E.; Milla M.; Thrombosis in inflammatory bowel diseases: What\u2019s the link? Thromb J 2015,13(1),14","journal-title":"Thromb J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1076029616632906","volume":"23","author":"Alkim H.","year":"2017","unstructured":"Alkim H.; Koksal A.R.; Boga S.; Sen I.; Alkim C.; Etiopathogenesis, prevention, and treatment of thromboembolism in inflammatory bowel disease. Clin Appl Thromb Hemost 2017,23(6),501-510","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"13863","DOI":"10.3748\/wjg.v20.i38.13863","volume":"20","author":"Zezos P.","year":"2014","unstructured":"Zezos P.; Kouklakis G.; Saibil F.; Inflammatory bowel disease and thromboembolism. World J Gastroenterol 2014,20(38),13863-13878","journal-title":"World J Gastroenterol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cgh.2019.12.043","volume":"19","author":"Lagrange J.","year":"2021","unstructured":"Lagrange J.; Lacolley P.; Wahl D.; Peyrin-Biroulet L.; Regnault V.; Shedding light on hemostasis in patients with inflammatory bowel diseas-es. Clin Gastroenterol Hepatol 2021,19(6),1088-1097.e6","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/gut.34.2.247","volume":"34","author":"Webberley M.J.","year":"1993","unstructured":"Webberley M.J.; Hart M.T.; Melikian V.; Thromboembolism in inflammatory bowel disease: Role of platelets. Gut 1993,34(2),247-251","journal-title":"Gut"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e6323","DOI":"10.1097\/MD.0000000000006323","volume":"96","author":"Ye L.","year":"2017","unstructured":"Ye L.; Zhang Y.P.; Yu N.; Jia Y.X.; Wan S.J.; Wang F.Y.; Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammato-ry bowel disease. Medicine 2017,96(11),e6323","journal-title":"Medicine"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.crohns.2012.05.016","volume":"7","author":"Palkovits J.","year":"2013","unstructured":"Palkovits J.; Novacek G.; Kollars M.; Tissue factor exposing microparticles in inflammatory bowel disease. J Crohn\u2019s Colitis 2013,7(3),222-229","journal-title":"J Crohn\u2019s Colitis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2169\/internalmedicine.46.0237","volume":"46","author":"Kume K.","year":"2007","unstructured":"Kume K.; Yamasaki M.; Tashiro M.; Yoshikawa I.; Otsuki M.; Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis. Intern Med 2007,46(17),1323-1330","journal-title":"Intern Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/1076029611405034","volume":"17","author":"Alkim H.","year":"2011","unstructured":"Alkim H.; Ayaz S.; Alkim C.; Ulker A.; Sahin B.; Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease. Clin Appl Thromb Hemost 2011,17(6),600-604","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/gut.38.5.733","volume":"38","author":"Hudson M.","year":"1996","unstructured":"Hudson M.; Chitolie A.; Hutton R.A.; Smith M.S.; Pounder R.E.; Wakefield A.J.; Thrombotic vascular risk factors in inflammatory bowel dis-ease. Gut 1996,38(5),733-737","journal-title":"Gut"},{"key":"ref=45","first-page":"1442","volume":"7","author":"Dolapcioglu C.","year":"2014","unstructured":"Dolapcioglu C.; Soylu A.; Kendir T.; Coagulation parameters in inflammatory bowel disease. Int J Clin Exp Med 2014,7(5),1442-1448","journal-title":"Int J Clin Exp Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","volume":"158","author":"Xiao F.","year":"2020","unstructured":"Xiao F.; Tang M.; Zheng X.; Liu Y.; Li X.; Shan H.; Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020,158(6),1831-1833.e3","journal-title":"Gastroenterology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2020.03.065","volume":"159","author":"Cheung K.S.","year":"2020","unstructured":"Cheung K.S.; Hung I.F.N.; Chan P.P.Y.; Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a hong kong cohort: Systematic review and meta-analysis. Gastroenterology 2020,159(1),81-95","journal-title":"Gastroenterology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"111233","DOI":"10.1016\/j.biopha.2021.111233","volume":"135","author":"Yang C.","year":"2021","unstructured":"Yang C.; Xiao S.Y.; COVID-19 and inflammatory bowel disease: A pathophysiological assessment. Biomed Pharmacother 2021,135,111233","journal-title":"Biomed Pharmacother"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.14309\/ajg.0000000000000830","volume":"115","author":"Papa A.","year":"2020","unstructured":"Papa A.; Gasbarrini A.; Tursi A.; Epidemiology and the impact of therapies on the outcome of COVID-19 in patients with inflammatory bowel disease. Am J Gastroenterol 2020,115(10),1722-1724","journal-title":"Am J Gastroenterol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","volume":"395","author":"Feldmann M.","year":"2020","unstructured":"Feldmann M.; Maini R.N.; Woody J.N.; Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet 2020,395(10234),1407-1409","journal-title":"Lancet"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/gutjnl-2020-321760","volume":"70","author":"Bezzio C.","year":"2021","unstructured":"Bezzio C.; Manes G.; Bini F.; Pellegrini L.; Saibeni S.; Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: A stone for two birds. Gut 2021,70(3),623-624","journal-title":"Gut"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","volume":"80","author":"Rizk J.G.","year":"2020","unstructured":"Rizk J.G.; Kalantar-Zadeh K.; Mehra M.R.; Lavie C.J.; Rizk Y.; Forthal D.N.; Pharmaco-immunomodulatory therapy in COVID-19. Drugs 2020,80(13),1267-1292","journal-title":"Drugs"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.gastro.2020.09.029","volume":"160","author":"Su&#xE1;rez-Fari&#xF1;as M.","year":"2021","unstructured":"Su&#xE1;rez-Fari&#xF1;as M.; Tokuyama M.; Wei G.; Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2-related disease. Gastroenterology 2021,160(1),287-301.e20","journal-title":"Gastroenterology"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1053\/j.gastro.2020.05.066","volume":"159","author":"Lukin D.J.","year":"2020","unstructured":"Lukin D.J.; Kumar A.; Hajifathalian K.; Baseline disease activity and steroid therapy stratify risk of COVID-19 in patients with inflam-matory bowel disease. Gastroenterology 2020,159(4),1541-1544.e2","journal-title":"Gastroenterology"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ueg2.12049","volume":"9","author":"Ludvigsson J.F.","year":"2021","unstructured":"Ludvigsson J.F.; Axelrad J.; Halfvarson J.; Inflammatory bowel disease and risk of severe COVID\u201019: A nationwide population\u2010based cohort study in Sweden. United European Gastroenterol J 2021,9(2),177-192","journal-title":"United European Gastroenterol J"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/apt.15804","volume":"52","author":"Taxonera C.","year":"2020","unstructured":"Taxonera C.; Sagastagoitia I.; Alba C.; Ma&#xF1;as N.; Olivares D.; Rey E.; 2019 novel coronavirus disease (COVID-19) in patients with inflamma-tory bowel diseases. Aliment Pharmacol Ther 2020,52(2),276-283","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1053\/j.gastro.2021.06.012","volume":"161","author":"Mahmud N.","year":"2021","unstructured":"Mahmud N.; Weiss A.; Trivedi C.; Yang Y.X.; Lewis J.; Khan N.; Risk of venous thromboembolism among patients with inflammatory bowel disease who contract severe acute respiratory syndrome coronavirus 2. Gastroenterology 2021,161(5),1709-1711.e1","journal-title":"Gastroenterology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s40264-020-00958-9","volume":"43","author":"Vallejo-Yag&#xFC;e E.","year":"2020","unstructured":"Vallejo-Yag&#xFC;e E.; Weiler S.; Micheroli R.; Burden A.M.; Thromboembolic safety reporting of tofacitinib and baricitinib: An analysis of the WHO vigibase. Drug Saf 2020,43(9),881-891","journal-title":"Drug Saf"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/ibd\/izaa303","volume":"27","author":"Agrawal M.","year":"2021","unstructured":"Agrawal M.; Brenner E.J.; Zhang X.; Characteristics and outcomes of IBD patients with COVID-19 on tofacitinib therapy in the SE-CURE-IBD registry. Inflamm Bowel Dis 2021,27(4),585-589","journal-title":"Inflamm Bowel Dis"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/ibd\/izab051","volume":"27","author":"Reuken P.A.","year":"2021","unstructured":"Reuken P.A.; Teich N.; Stallmach A.; Safety of tofacitinib in the COVID-19 pandemic\u2014enough is not enough. Inflamm Bowel Dis 2021,27(8),e89","journal-title":"Inflamm Bowel Dis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"Tsochatzis E.A.","year":"2014","unstructured":"Tsochatzis E.A.; Bosch J.; Burroughs A.K.; Liver cirrhosis. Lancet 2014,383(9930),1749-1761","journal-title":"Lancet"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJMra1011170","volume":"365","author":"Tripodi A.","year":"2011","unstructured":"Tripodi A.; Mannucci P.M.; The coagulopathy of chronic liver disease. N Engl J Med 2011,365(2),147-156","journal-title":"N Engl J Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/ajg.2016.498","volume":"112","author":"Tripodi A.","year":"2017","unstructured":"Tripodi A.; Primignani M.; Mannucci P.M.; Caldwell S.H.; Changing concepts of cirrhotic coagulopathy. Am J Gastroenterol 2017,112(2),274-281","journal-title":"Am J Gastroenterol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ajg.2008.34","volume":"104","author":"S&#xF8;gaard K.K.","year":"2009","unstructured":"S&#xF8;gaard K.K.; Horv&#xE1;th-Puh&#xF3; E.; Gr&#xF8;nb&#xE6;k H.; Jepsen P.; Vilstrup H.; S&#xF8;rensen H.T.; Risk of venous thromboembolism in patients with liver disease: A nationwide population-based case-control study. Am J Gastroenterol 2009,104(1),96-101","journal-title":"Am J Gastroenterol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gut.2004.042796","volume":"54","author":"Francoz C.","year":"2005","unstructured":"Francoz C.; Belghiti J.; Vilgrain V.; Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation. Gut 2005,54(5),691-697","journal-title":"Gut"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cgh.2010.05.014","volume":"8","author":"Wu H.","year":"2010","unstructured":"Wu H.; Nguyen G.C.; Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol 2010,8(9),800-805.e1","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","volume":"31","author":"Tsochatzis E.A.","year":"2010","unstructured":"Tsochatzis E.A.; Senzolo M.; Germani G.; Gatt A.; Burroughs A.K.; Systematic review: Portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther 2010,31(3),366-374","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","volume":"157","author":"O\u2019Leary J.G.","year":"2019","unstructured":"O\u2019Leary J.G.; Greenberg C.S.; Patton H.M.; Caldwell S.H.; AGA clinical practice update: coagulation in cirrhosis. Gastroenterology 2019,157(1),34-43.e1","journal-title":"Gastroenterology"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/hep.31684","volume":"74","author":"Saviano A.","year":"2021","unstructured":"Saviano A.; Wrensch F.; Ghany M.G.; Baumert T.F.; Liver disease and coronavirus disease 2019: From pathogenesis to clinical care. Hepatology 2021,74(2),1088-1100","journal-title":"Hepatology"},{"key":"ref=70","first-page":"50","volume":"5","author":"Noor M.T.","year":"2017","unstructured":"Noor M.T.; Manoria P.; Immune dysfunction in cirrhosis. J Clin Transl Hepatol 2017,5(1),50-58","journal-title":"J Clin Transl Hepatol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","volume":"61","author":"Albillos A.","year":"2014","unstructured":"Albillos A.; Lario M.; &#xC1;lvarez-Mon M.; Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. J Hepatol 2014,61(6),1385-1396","journal-title":"J Hepatol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","volume":"18","author":"Marjot T.","year":"2021","unstructured":"Marjot T.; Webb G.J.; Barritt A.S.; COVID-19 and liver disease: Mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021,18(5),348-364","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1053\/j.gastro.2020.04.064","volume":"159","author":"Singh S.","year":"2020","unstructured":"Singh S.; Khan A.; Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the united states: A multicenter research network study. Gastroenterology 2020,159(2),768-771.e3","journal-title":"Gastroenterology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"587350","DOI":"10.3389\/fmed.2020.587350","volume":"7","author":"Jiang M.","year":"2021","unstructured":"Jiang M.; Mu J.; Shen S.; Zhang H.; COVID-19 with preexisting hypercoagulability digestive disease. Front Med 2021,7,587350","journal-title":"Front Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"000(000): 000","DOI":"10.14218\/JCTH.2021.00055","author":"Premkumar M","year":"2021","unstructured":"Premkumar M; Kedarisetty CK; Cytokine Storm of COVID-19 and its impact on patients with and without chronic liver disease. J Clin Transl Hepatol 2021,000(000): 000"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1111\/liv.14601","volume":"40","author":"Sonzogni A.","year":"2020","unstructured":"Sonzogni A.; Previtali G.; Seghezzi M.; Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular altera-tions. Liver Int 2020,40(9),2110-2116","journal-title":"Liver Int"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"100303","DOI":"10.1016\/j.jhepr.2021.100303","volume":"3","author":"Kaur S.","year":"2021","unstructured":"Kaur S.; Hussain S.; Kolhe K.; Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacteri-al sepsis. JHEP Reports 2021,3(4),100303","journal-title":"JHEP Reports"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"e01094","DOI":"10.1016\/j.idcr.2021.e01094","volume":"24","author":"Miyazato Y.","year":"2021","unstructured":"Miyazato Y.; Ishikane M.; Inada M.; Ohmagari N.; Acute portal vein thrombosis with COVID-19 and cirrhosis. IDCases 2021,24,e01094","journal-title":"IDCases"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jceh.2021.10.149","volume":"12","author":"Premkumar M.","year":"2022","unstructured":"Premkumar M.; Bhujade H.; Karki T.; New portal vein thrombosis in cirrhosis - is the thrombophilia exacerbated due to vaccine or COVID-19? J Clin Exp Hepatol 2022,12(3),1025-1028","journal-title":"J Clin Exp Hepatol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","volume":"391","author":"Lebwohl B.","year":"2018","unstructured":"Lebwohl B.; Sanders D.S.; Green P.H.R.; Coeliac disease. Lancet 2018,391(10115),70-81","journal-title":"Lancet"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","volume":"7","author":"Al-Toma A.","year":"2019","unstructured":"Al-Toma A.; Volta U.; Auricchio R.; European society for the study of coeliac disease (ESsCD) guideline for coeliac disease and other gluten\u2010related disorders. United European Gastroenterol J 2019,7(5),583-613","journal-title":"United European Gastroenterol J"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41575-020-00378-1","volume":"18","author":"Kivel&#xE4; L.","year":"2021","unstructured":"Kivel&#xE4; L.; Caminero A.; Leffler D.A.; Pinto-Sanchez M.I.; Tye-Din J.A.; Lindfors K.; Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol 2021,18(3),181-195","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5236918","volume":"2017","author":"Dumic I.","year":"2017","unstructured":"Dumic I.; Martin S.; Salfiti N.; Watson R.; Alempijevic T.; Deep venous thrombosis and bilateral pulmonary embolism revealing silent celiac disease: Case report and review of the literature. Case Rep Gastrointest Med 2017,2017,1-8","journal-title":"Case Rep Gastrointest Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12016-010-8240-0","volume":"42","author":"Rubio-Jurado B.","year":"2012","unstructured":"Rubio-Jurado B.; I&#xF1;iguez-Franco P.; Reyes P.A.; The clinical significance of coagulation and the inflammatory response in autoimmuni-ty. Clin Rev Allergy Immunol 2012,42(2),172-180","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11845-020-02315-2","volume":"190","author":"Fousekis F.S.","year":"2021","unstructured":"Fousekis F.S.; Beka E.T.; Mitselos I.V.; Milionis H.; Christodoulou D.K.; Thromboembolic complications and cardiovascular events associated with celiac disease. Ir J Med Sci 2021,190(1),133-141","journal-title":"Ir J Med Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2141.2012.09030.x","volume":"157","author":"Johannesdottir S.A.","year":"2012","unstructured":"Johannesdottir S.A.; Erichsen R.; Horv&#xE1;th-Puh&#xF3; E.; Schmidt M.; S&#xF8;rensen H.T.; Coeliac disease and risk of venous thromboembolism: A na-tionwide population-based case-control study. Br J Haematol 2012,157(4),499-501","journal-title":"Br J Haematol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-2141.2007.06766.x","volume":"139","author":"Ludvigsson J.F.","year":"2007","unstructured":"Ludvigsson J.F.; Welander A.; Lassila R.; Ekbom A.; Montgomery S.M.; Risk of thromboembolism in 14 000 individuals with coeliac disease. Br J Haematol 2007,139(1),121-127","journal-title":"Br J Haematol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/jgh.13282","volume":"31","author":"Ungprasert P.","year":"2016","unstructured":"Ungprasert P.; Wijarnpreecha K.; Tanratana P.; Risk of venous thromboembolism in patients with celiac disease: A systematic review and meta-analysis. J Gastroenterol Hepatol 2016,31(7),1240-1245","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=89","first-page":"263","volume":"110","author":"Beyan E.","year":"2009","unstructured":"Beyan E.; Pamukcuoglu M.; Beyan C.; Deep vein thrombosis associated with celiac disease. Bratisl Lek Listy 2009,110(4),263-264","journal-title":"Bratisl Lek Listy"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/MEG.0b013e328328f47f","volume":"21","author":"Kochhar R.","year":"2009","unstructured":"Kochhar R.; Masoodi I.; Dutta U.; Celiac disease and budd chiari syndrome: Report of a case with review of literature. Eur J Gastroenterol Hepatol 2009,21(9),1092-1094","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/gastro\/gow030","volume":"6","author":"Jadallah K.A.","year":"2018","unstructured":"Jadallah K.A.; Sarsak E.W.; Khazaleh Y.M.; Barakat R.M.K.; Budd-chiari syndrome associated with coeliac disease: Case report and literature review. Gastroenterol Rep 2018,6(4),308-312","journal-title":"Gastroenterol Rep"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.gcb.2010.07.007","volume":"34","author":"Afredj N.","year":"2010","unstructured":"Afredj N.; Metatla S.; Faraoun S.A.; Association of budd-chiari syndrome and celiac disease. Gastroenterol Clin Biol 2010,34(11),621-624","journal-title":"Gastroenterol Clin Biol"},{"key":"ref=93","first-page":"953","volume":"19","author":"Zenjari T.","year":"1995","unstructured":"Zenjari T.; Boruchowicz A.; Desreumaux P.; Laberenne E.; Cortot A.; Colombel J.F.; Association of coeliac disease and portal venous throm-bosis. Gastroenterol Clin Biol 1995,19(11),953-954","journal-title":"Gastroenterol Clin Biol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa200","volume":"4","author":"Bouziane M.","year":"2020","unstructured":"Bouziane M.; Arous S.; Habbal R.; Cerebral venous thrombosis as a rare thromboembolic complication of celiac disease: A case report. Eur Heart J Case Rep 2020,4(5),1-5","journal-title":"Eur Heart J Case Rep"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/1076029610369799","volume":"17","author":"Do&#x11F;an M.","year":"2011","unstructured":"Do&#x11F;an M.; Peker E.; Akbayram S.; Cerebral venous sinus thrombosis in 2 children with celiac disease. Clin Appl Thromb Hemost 2011,17(5),466-469","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12890\/2016_000492","volume":"3","author":"Zoubeidi H.","year":"2016","unstructured":"Zoubeidi H.; Ben Salem T.; Ben Ghorbel I.; Houman M.H.; Central retinal vein occlusion revealing coelic disease. Eur J Case Rep Intern Med 2016,3(7),4","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00042737-200204000-00016","volume":"14","author":"Dickey W.","year":"2002","unstructured":"Dickey W.; Low serum vitamin B12 is common in coeliac disease and is not due to autoimmune gastritis. Eur J Gastroenterol Hepatol 2002,14(4),425-427","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.mayocp.2018.11.036","volume":"94","author":"Bledsoe A.C.","year":"2019","unstructured":"Bledsoe A.C.; King K.S.; Larson J.J.; Micronutrient deficiencies are common in contemporary celiac disease despite lack of overt malab-sorption symptoms. Mayo Clin Proc 2019,94(7),1253-1260","journal-title":"Mayo Clin Proc"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.3390\/nu5103975","volume":"5","author":"Wierdsma N.","year":"2013","unstructured":"Wierdsma N.; van Bokhorst-de van der Schueren M, Berkenpas M, Mulder C, van Bodegraven A. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients 2013,5(10),3975-3992","journal-title":"Nutrients"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1586\/17474124.2014.876360","volume":"8","author":"Theethira T.G.","year":"2014","unstructured":"Theethira T.G.; Dennis M.; Leffler D.A.; Nutritional consequences of celiac disease and the gluten-free diet. Expert Rev Gastroenterol Hepatol 2014,8(2),123-129","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12272-018-1016-4","volume":"41","author":"Kim J.","year":"2018","unstructured":"Kim J.; Kim H.; Roh H.; Kwon Y.; Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res 2018,41(4),372-383","journal-title":"Arch Pharm Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3109\/00365521.2012.706828","volume":"47","author":"Baydoun A.","year":"2012","unstructured":"Baydoun A.; Maakaron J.E.; Halawi H.; Abou Rahal J.; Taher A.T.; Hematological manifestations of celiac disease. Scand J Gastroenterol 2012,47(12),1401-1411","journal-title":"Scand J Gastroenterol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1365-2249.2001.01594.x","volume":"125","author":"O\u2019Keeffe J.","year":"2001","unstructured":"O\u2019Keeffe J.; Lynch S.; Whelan A.; Flow cytometric measurement of intracellular migration inhibition factor and tumour necrosis factor alpha in the mucosa of patients with coeliac disease. Clin Exp Immunol 2001,125(3),376-382","journal-title":"Clin Exp Immunol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/MPG.0b013e3181818fb9","volume":"47","author":"Garrote J.A.","year":"2008","unstructured":"Garrote J.A.; G&#xF3;mez-Gonz&#xE1;lez E.; Bernardo D.; Arranz E.; Chirdo F.; Celiac disease pathogenesis: The proinflammatory cytokine network. J Pediatr Gastroenterol Nutr 2008,47(S1),S27-S32","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1182\/blood.V72.5.1467.1467","volume":"72","author":"van Hinsbergh V.W.","year":"1988","unstructured":"van Hinsbergh V.W.; Kooistra T.; van den Berg E.A.; Princen H.M.; Fiers W.; Emeis J.J.; Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988,72(5),1467-1473","journal-title":"Blood"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1741-7015-11-89","volume":"11","author":"Lerner A.","year":"2013","unstructured":"Lerner A.; Agmon-Levin N.; Shapira Y.; The thrombophilic network of autoantibodies in celiac disease. BMC Med 2013,11(1),89","journal-title":"BMC Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/73-0891693021000005402","volume":"35","author":"Sj&#xF6;berg K.","year":"2002","unstructured":"Sj&#xF6;berg K.; Eriksson S.; Tenngart B.; Roth E.B.; Leffler H.; Stenberg P.; Factor XIII and tissue transglutaminase antibodies in coeliac and in-flammatory bowel disease. Autoimmunity 2002,35(5),357-364","journal-title":"Autoimmunity"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/MPG.0000000000001138","volume":"63","author":"Comba A.","year":"2016","unstructured":"Comba A.; &#xC7;altepe G.; Yan\u0131k K.; G&#xF6;r U.; Y&#xFC;ce &#xD6;.; Kalayc\u0131 A.G.; Assessment of endothelial dysfunction with adhesion molecules in patients with celiac disease. J Pediatr Gastroenterol Nutr 2016,63(2),247-252","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1540-8175.2011.01598.x","volume":"29","author":"Sari C.","year":"2012","unstructured":"Sari C.; Bayram N.A.; Do&#x11F;an F.E.; The evaluation of endothelial functions in patients with celiac disease. Echocardiography 2012,29(4),471-477","journal-title":"Echocardiography"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.dld.2017.11.018","volume":"50","author":"Laine O.","year":"2018","unstructured":"Laine O.; Pitk&#xE4;nen K.; Lindfors K.; Elevated serum antiphospholipid antibodies in adults with celiac disease. Dig Liver Dis 2018,50(5),457-461","journal-title":"Dig Liver Dis"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"gutjnl-2021-325930","DOI":"10.1136\/gutjnl-2021-325930","author":"Mansoor E","year":"2021","unstructured":"Mansoor E; Alikhan MM; Perez JA; Schlick K; Abou Saleh M; Rubio-Tapia A; Clinical characteristics, hospitalisation and mortality rates of COVID-19 among patients with coeliac disease in the USA: A multicentre network study. Gut 2021,gutjnl-2021-325930"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/CLEP.S294391","volume":"13","author":"Lebwohl B.","year":"2021","unstructured":"Lebwohl B.; Larsson E.; S&#xF6;derling J.; Risk of severe Covid-19 in patients with celiac disease: A population-based cohort study. Clin Epidemiol 2021,13,121-130","journal-title":"Clin Epidemiol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jnma.2021.12.003","volume":"114","author":"Chen C.","year":"2022","unstructured":"Chen C.; Li Y.W.; Shi P.F.; Qian S.X.; Acute Mesenteric Ischemia in Patients with COVID-19: Review of the literature. J Natl Med Assoc 2022,114(1),47-55","journal-title":"J Natl Med Assoc"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220922095913","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209058\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220922095913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T06:47:02Z","timestamp":1672037222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209058\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":113,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220922095913","relation":{},"ISSN":["1389-4501"],"issn-type":[{"type":"print","value":"1389-4501"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}